Silicon Valley Bank January 9, 2025

Key takeaways

Our Healthcare Investments and Exits report shows a surge in biotech AI investment, strong early-stage momentum and mixed signals from valuation trends.

$5.6B

Invested in biotech AI in 2024

Driven largely by mega-deals, investment in biotech AI nearly tripled.

Nearly 40%

Of all healthcare deals with a declared Series went to seed-stage companies

Seed and Series A rounds claimed a majority of healthcare deals in 2024.

1

Number of healthcare subsectors experiencing a drop in down and flat rounds

Market corrections may be starting to wind down in biotech, devices and diagnostics/tools.

The Data

2024 was...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Digital Health, Investments, Mergers & Acquisitions / JV, Pharma / Biotech, Survey / Study, Technology, Trends
Healthcare venture capital investment amplified by AI in 2024: report
Senate report blasts PE ownership in healthcare: 10 things to know
Infinite Reality raises $3B to increase its immersive tech portfolio
Providence spins out venture capital arm, invests $150M in 3rd fund
Microsoft to Invest $3 Billion in Cloud and AI Infrastructure in India

Share This Article